Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NLRP3 is a key component of the innate immune system that forms an inflammasome complex upon activation, leading to the activation of caspase-1 and the release of pro-inflammatory cytokines IL-1β and IL-18. Overactivation of NLRP3 is implicated in various neurodegenerative and cardiometabolic diseases.
Selective inhibition of CNS-resident NLRP3 inflammasome
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3).